We provide integrated solutions covering every stage from early-stage biomarker discovery and pilot validation to large-scale research cohort analysis, ensuring a seamless transition throughout your entire drug development pipeline.
Immune Checkpoint Ligand Expression Profiling Service
Creative Biolabs provides an end-to-end analytical platform for the detailed characterization of the immune landscape within tissue samples. Our services include the identification and quantification of diverse checkpoint ligands, spatial mapping of protein expression, and bioinformatic integration of multi-omic data. By partnering with us, clients gain a deep understanding of immune evasion mechanisms in their research models, enabling the identification of novel targets and the optimization of combination therapy strategies. You can expect high-resolution data that clarifies the spatial relationships between tumor cells and immune infiltrates, ultimately facilitating more informed decisions in your discovery pipeline.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Scientific Background of Immune Checkpoint Ligand Profiling
Current oncology research frequently encounters a response ceiling where established inhibitors fail in specific biological models. Recent scientific literature validates those alternative ligands, function as redundant suppressive signals within the tumor microenvironment. Creative Biolabs' profiling service accurately identifies these non-canonical pathways, facilitating the design of innovative synergistic combinations. High-resolution ligand mapping has become a vital cornerstone of modern immunotherapy discovery, allowing researchers to visualize and quantify the complex molecular interactions driving immune evasion.
Request a Consultation →
Fig.1 Receptor-ligand interaction between macrophages and tumor cells in pro-tumor immunity. 1
What We Can Offer
One-stop Profiling Service
Fully Customized Panel Design
Our team optimizes antibody selection to facilitate high-specificity expression analysis of niche or proprietary targets and human tissue samples, tailoring every panel to meet your specific research objectives.
High-Volume Processing Capability
We utilize high-throughput automated scanning and sequence-based platforms capable of processing numerous samples simultaneously, delivering extensive data points per slide to maximize the depth of your tissue analysis.
Advanced Quality Control
Our proprietary workflows integrate Quality-by-Design principles and process analytical techniques to ensure high reproducibility in ligand quantification, maintaining the absolute integrity of your data across all study sets.
How Creative Biolabs Can Assist Your Project
Highlights
Proven Scientific Leadership
Creative Biolabs provides more than raw data; we offer over twenty years of deep experience to ensure your research project benefits from established expertise and specialized biological knowledge.
Advanced Vascular Insights
Our unique approach allows for the identification of ligands within the tissue vasculature, offering a level of detail that provides a distinct advantage for your research.
Expert Biological Interpretation
We distinguish our offerings from standard providers by combining high-resolution data with expert analysis, ensuring every finding is contextualized within the complex tissue environment for better insights.
Ready-to-Use Research Data
We guarantee that all findings are robust, high-quality, and prepared for your reporting needs, helping your team meet critical development milestones and publication deadlines with confidence.
Experience the Creative Biolabs Advantage and secure a competitive edge in your immunotherapy programs - Get a Quote Today.
Customer Reviews
-
Accelerated Target Validation
The inclusion of B7-H3 vascular mapping has improved our target selection process. We found the data robust and well-suited for our internal research requirements, facilitating a more streamlined approach to validation and reporting. - S**h. M. -
Superior Spatial Resolution
Identifying VISTA expression in acidic microenvironments has improved our ability to distinguish between different phenotypes. The high-resolution results provided clear, actionable insights that were vital for characterizing the complex biological niches in our models. - Dr. K***n. W.
FAQs
How does this service compare to standard IHC?
Standard IHC often misses low-density ligands. We utilize advanced detection platforms to identify low-abundance targets while providing essential cellular context that traditional bulk methods cannot offer for complex research samples.
Can you handle rare or limited research samples?
Yes, our specialized multiplexed approach allows for the efficient detection of multiple markers on a single slide, significantly maximizing the data yield from small or extremely precious tissue research biopsies.
Related Services
Tumor Antigen Presentation Defect Analysis Service
This service identifies disruptions in MHC pathways and processing machinery, providing critical insights into why tumor cells remain invisible to the immune system despite the presence of high-density checkpoint ligands.
Learn More →Cytokine/Chemokine mediated Immunosuppression Assessment Service
This service evaluates the soluble inflammatory landscape, identifying how specific secreted factors recruit suppressive cell populations or physically exclude effector lymphocytes from the microenvironment, complementing your ligand expression data.
Learn More →How to Contact Us
Creative Biolabs is dedicated to providing high-resolution biological insights required to understand and overcome resistance in modern immuno-oncology research. By profiling the next generation of immune checkpoint ligands, we empower your R&D team to make faster, more informed decisions and build a robust foundation for your therapeutic pipeline.
We encourage early-stage collaboration to ensure the best possible design for your custom study. Our global specialist team is available to assist with logistics, sample handling requirements, and panel selection - Get Started Today.
Reference
- Yang, Yuanyuan et al. "Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects." Cancers vol. 14,23 5963. 2 Dec. 2022. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers14235963
Download our brochureLoading case studies...
Online Inquiry